Lee Se Yun, Choi Min Chul, Kwon Bo Ram, Jung Sang Geun, Park Hyun, Joo Won Duk, Lee Chan, Lee Je Ho, Lee Joon Mo
Department of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
Obstet Gynecol Sci. 2017 May;60(3):289-295. doi: 10.5468/ogs.2017.60.3.289. Epub 2017 May 15.
To compare the oncologic and obstetric outcomes in reproductive-age females with borderline ovarian tumors (BOTs) treated with cyst enucleation (CE) or unilateral salpingo-oophorectomy (USO).
The medical records of patients with BOTs treated between 1998 and 2014 were retrospectively reviewed. The recurrence rates in the USO and CE groups were compared, and the postoperative obstetric outcomes were assessed via telephone survey.
Eighty-nine patients with BOTs underwent USO, and 19 underwent CE. Of these, six patients had recurrent BOTs. The recurrence rate was significantly lower in the USO group (3/89, 3.4%) than in the CE group (3/19, 15.8%) (=0.032). All patients with recurrent disease were successfully treated with further surgery. Of the 76 patients interviewed by telephone, 71 (93.4%) resumed regular menstruation after surgery. Twenty-six of the 32 patients (81.3%) who attempted to conceive had successful pregnancies. USO (19/24, 79.2%), like CE (7/8, 87.5%), resulted in favorable pregnancy rates for patients with BOTs.
USO is a suitable fertility-preserving surgery for women with BOTs. CE is also an acceptable option for select patients.
比较采用囊肿剥除术（CE）或单侧输卵管卵巢切除术（USO）治疗的育龄期交界性卵巢肿瘤（BOT）女性的肿瘤学和产科结局。
回顾性分析1998年至2014年间接受治疗的BOT患者的病历。比较USO组和CE组的复发率，并通过电话调查评估术后产科结局。
89例BOT患者接受了USO，19例接受了CE。其中，6例患者出现BOT复发。USO组的复发率（3/89，3.4%）显著低于CE组（3/19，15.8%）（P=0.032）。所有复发患者均通过进一步手术成功治疗。在接受电话采访的76例患者中，71例（93.4%）术后恢复正常月经。在32例尝试受孕的患者中，26例（81.3%）成功怀孕。USO（19/24，79.2%）与CE（7/8，87.5%）一样，对BOT患者产生了良好的妊娠率。
USO是适合BOT女性的保留生育功能手术。CE对部分患者也是一种可接受的选择。
